metabol
epimediumderiv
flavonoid
glycosid
ef
icariin
main
compon
rabbit
intestin
flora
inhibit
gluconolacton
investig
paper
help
reveal
metabol
pathway
ef
rabbit
identifi
vivo
bioactiv
compon
ef
prevent
steroidassoci
osteonecrosi
method
ef
incub
anaerob
rabbit
intestin
flora
watersatur
ethyl
acet
use
sampl
extract
differ
time
point
furthermor
gluconolacton
ad
differ
concentr
studi
inhibit
metabol
ef
rabbit
intestin
flora
separ
perform
od
column
gradient
elut
acetonitrilewat
includ
formic
acid
respect
mobil
phase
detect
wavelength
nm
result
ef
metabol
icarisid
ii
h
icaritin
incub
h
gluconolacton
show
inhibit
ef
metabol
rabbit
intestin
flora
concentrationdepend
manner
conclus
ef
found
metabol
rapidli
hydrolysi
rabbit
intestin
flora
produc
icarisid
ii
icaritin
total
inhibit
achiev
gluconolacton
concentr
key
word
epimediumderiv
flavonoid
glycosid
prevent
steroidassoci
osteonecrosi
metabol
rabbit
intestin
flora
gluconolacton
inhibit
clc
number
document
code
articl
id
correspond
author
yao
zhihong
associ
prof
tradit
herba
epimedii
use
chines
herbal
medicin
invigor
kidney
strengthen
sinew
bone
dispel
wind
elimin
damp
modern
pharmacolog
research
indic
icariin
benefici
vasodilat
immunoregul
antiosteoporosi
recent
studi
also
show
oral
administr
epimediumderiv
flavonoid
glycosid
ef
icariin
main
compon
could
exert
benefici
effect
prevent
steroidassoci
osteonecrosi
rabbit
model
inhibit
intravascularthrombosi
extravascularlipiddeposit
studi
vitro
show
icaritin
ef
display
direct
effect
protect
vein
endotheli
cell
inhibit
lipid
deposit
dosedepend
manner
suggest
ef
might
use
prodrug
exert
effect
metabol
aglycon
vivo
bioactiv
prevent
antisteroidassoci
osteonecrosi
sinc
intestin
flora
hydrolyz
glycosid
drug
metabol
oral
administ
glycosid
drug
intestin
flora
may
affect
bioavail
vivo
bioactiv
necessari
studi
metabol
ef
intestin
flora
investig
metabol
icariin
intestin
flora
rat
human
carri
howev
metabol
ef
rabbit
intestin
flora
still
difficult
estim
differ
metabol
abil
intestin
flora
among
differ
anim
speci
therefor
paper
mark
first
time
metabol
ef
intestin
flora
rabbit
studi
gluconolacton
type
specif
inhibitor
extens
use
limit
hydrolysi
flavonoid
glycosid
therefor
inhibit
metabol
ef
rabbit
intestin
flora
gluconolacton
differ
concentr
also
investig
paper
present
work
might
help
reveal
metabol
pathway
ef
rabbit
well
vivo
bioactiv
compon
ef
prevent
steroidassoci
osteonecrosi
epimediumderiv
flavonoid
glycosid
puriti
icariin
epimedosid
hexandrasid
f
epimedin
epimedin
epimedin
c
icarisid
ii
provid
beij
tongrentang
health
pharmaceut
co
ltd
beij
china
icariin
puriti
icarisid
ii
puriti
icaritin
puriti
purchas
shanghai
winherb
medic
scienc
co
ltd
shanghai
china
icarisid
purchas
tianjin
jianfeng
natur
product
r
co
ltd
tianjin
china
desmethylicaritin
puriti
selfmad
laboratori
gluconolacton
puriti
purchas
sigma
st
loui
mo
usa
acetonitril
hplc
grade
purchas
dikma
technolog
inc
beij
china
methanol
hplc
grade
purchas
yuwang
co
ltd
shandong
china
watson
water
purchas
beij
watson
water
co
ltd
beij
china
reagent
analyt
grade
agil
hplc
system
consist
degass
quaternari
pump
autosampl
thermostat
column
compart
multipl
wavelength
detector
use
hplc
analysi
sampl
microvortex
apparatu
shanghai
huxi
analyt
instrument
factori
china
use
vortex
sampl
highspe
bench
centrifug
shanghai
ant
scientif
instrument
factori
china
use
centrifug
sampl
ultrason
wave
purifi
kunshan
ultrason
instrument
co
ltd
use
sampl
ultrason
intestin
incub
experi
carri
l
anaerob
incub
bag
mgc
mitsubishi
ga
chemic
co
inc
chiyodaku
japan
l
anaerob
incub
pot
labm
labm
biotech
co
ltd
guangzhou
china
laiheng
nitrogen
blow
instrument
beij
laiheng
scientif
co
ltd
beij
china
use
sampl
condens
four
newzealand
male
rabbit
bodi
weight
kg
purchas
experiment
anim
center
guangdong
provinc
kept
anim
room
constant
temperatur
humid
h
light
per
day
access
water
food
ad
libitum
ml
solut
k
hpo
ml
b
solut
kh
po
nacl
nh
cacl
mgso
ml
c
solut
na
co
g
lcystein
ml
lascorb
acid
g
eurythrol
g
trypton
g
nutrient
agar
mix
togeth
dilut
distil
water
l
solut
adjust
ph
hcl
fresh
fece
rabbit
homogen
normal
salin
solut
ratio
g
ml
immedi
follow
filtrat
gauz
ml
filtrat
mix
ml
anaerob
cultur
solut
prepar
ml
intestin
flora
cultur
solut
mg
ef
accur
weigh
first
dissolv
methanol
dilut
suffici
normal
salin
solut
creat
final
volum
ml
yield
ef
standard
solut
concentr
sampl
pretreat
liquidliquid
extract
thrice
round
watersatur
ethyl
acet
ad
ml
sampl
incub
anaerob
vortex
centrifug
min
supernat
obtain
three
round
liquidliquid
extract
combin
dri
nitrogen
stream
room
temperatur
residu
redissolv
methanol
ultrason
min
vortex
min
supernat
obtain
centrifug
transfer
borosil
glass
insert
place
insid
sampl
vial
hplc
analysi
chromatograph
separ
perform
xbc
column
mm
mm
id
coupl
phenomenexc
guard
column
mm
mm
id
optimum
separ
achiev
binari
mobil
phase
flow
rate
column
temperatur
held
mobil
phase
consist
acetonitril
b
water
vv
includ
formic
acid
respect
gradient
program
follow
min
b
min
b
min
b
min
b
min
b
detect
wavelength
refer
wavelength
set
nm
nm
respect
final
sampl
inject
automat
hplc
system
report
metabolit
epimedium
vivo
includ
icariin
parent
drug
icarisid
icarisid
ii
desmethylicaritin
icaritin
therefor
five
refer
substanc
select
mix
prepar
sampl
mix
refer
substanc
use
identif
metabolit
ef
rabbit
intestin
flora
studi
ef
metabol
rabbit
intestin
flora
piec
ml
polypropylen
centrifug
tube
use
ad
ef
standard
solut
well
intestin
flora
cultur
solut
incub
anaerob
five
tube
taken
time
point
h
sampl
pretreat
immedi
refer
pretreat
sampl
immedi
analyz
hplc
condit
order
studi
metabol
ef
intestin
flora
rabbit
addit
ef
incub
anaerob
cultur
solut
neg
control
subject
procedur
rabbit
intestin
flora
describ
investig
whether
ef
metabol
anaerob
cultur
solut
differ
amount
gluconolacton
ad
three
portion
rabbit
intestin
flora
fluid
obtain
three
differ
concentr
low
concentr
intermedi
concentr
high
concentr
rabbit
intestin
flora
cultur
solut
one
three
prepar
gluconolacton
concentr
piec
ml
polypropylen
centrifug
tube
use
ad
ef
standard
solut
well
correspond
rabbit
intestin
flora
cultur
solut
incub
anaerob
five
tube
taken
time
point
h
sampl
pretreat
immedi
pretreat
sampl
immedi
analyz
hplc
condit
order
studi
inhibit
metabol
ef
rabbit
intestin
flora
gluconolacton
experi
ef
shown
metabol
rabbit
intestin
flora
quickli
evidenc
complet
elimin
icariin
main
compon
ef
parent
drug
incub
h
metabolit
icarisid
ii
reach
maximum
peak
area
simultan
decreas
gradual
incub
incub
h
anoth
metabolit
icaritin
gener
peak
area
could
increas
gradual
upon
longer
incub
time
mean
profil
correspond
chromatogram
shown
fig
respect
metabol
ef
anaerob
cultur
solut
also
investig
neg
control
result
show
ef
could
metabol
anaerob
cultur
solut
inhibit
ef
metabol
rabbit
intestin
flora
differ
concentr
gluconolacton
perform
gluconolacton
show
kind
inhibit
low
concentr
rabbit
intestin
flora
ie
amount
icarisid
ii
icaritin
decreas
residu
amount
icariin
increas
fig
enhanc
inhibit
gluconolacton
shown
intermedi
concentr
rabbit
intestin
flora
ie
icaritin
format
inhibit
amount
icarisid
ii
decreas
time
point
sd
icarisid
ii
less
fig
gluconolacton
show
complet
inhibit
high
concentr
rabbit
intestin
flora
neither
metabolit
icarisid
ii
icaritin
form
icariin
metabol
time
point
sd
icariin
less
fig
brief
certain
concentr
gluconolacton
show
inhibit
metabol
ef
rabbit
intestin
flora
concentrationdepend
manner
gluconolacton
could
total
inhibit
metabol
ef
rabbit
intestin
flora
basi
result
intestin
flora
rabbit
ef
icariin
main
compon
thought
metabol
hydrolysi
first
produc
icarisid
ii
remov
glucos
icarisid
ii
metabol
produc
icaritin
remov
rhamnos
fig
correspond
flow
diagram
metabol
ef
rabbit
intestin
flora
experi
metabol
icariin
human
intestin
flora
report
final
metabolit
icaritin
produc
consid
icaritin
ef
display
direct
protect
effect
dosedepend
steroidinduc
cell
damag
model
vitro
bioactiv
evalu
ef
could
reduc
risk
steroidassoci
osteoncrosi
rabbit
model
epimedium
extract
could
reduc
probabl
steroidassoci
osteoncrosi
sar
patient
clinic
evidencebas
medicin
icaritin
might
impli
exact
vivo
bioactiv
compon
ef
prevent
steroidassoci
osteonecrosi
gluconolacton
found
concentrationdepend
inhibit
metabol
ef
rabbit
intestin
flora
studi
show
gluconolacton
may
use
potenti
tool
medicin
investig
whether
ef
could
reduc
risk
steroidassoci
osteoncrosi
rabbit
vivo
metabol
inhibit
gluconolacton
accordingli
confirm
whether
ef
might
act
prodrug
prevent
steroidassoci
osteonecrosi
summari
partial
research
carri
studi
aim
reveal
vivo
bioactiv
compon
ef
prevent
steroidassoci
osteonecrosi
nevertheless
investig
vivo
metabol
bioactiv
evalu
ef
use
rabbit
model
launch
help
achiev
object
